Patents 962show all

  • 351
    A61K - Preparations for medical, dental, or toilet purposes
  • 196
    C07K - Peptides
  • 183
    C07D - Heterocyclic compounds
  • 82
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 73
    C12N - Microorganisms or enzymes
  • 40
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 37
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 28
    A61F - Filters implantable into blood vessels
  • 25
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 16
    Y02A - Technologies for adaptation to climate change

Clinical Trials 20show all

11Phase 16Phase 21Early Phase 11N/A1Phase 3

SEC Filings show all


186
8-K

60
10-Q

19
10-K

2
D

1
S-1

Contact Information

Lexington, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-05-04$964,000$964,000Equity
2007-08-13Unknown Unknown Other (Paper Filing)

Key Executives

  • Daniel R. Passeri
    Executive Officer, Director
  • Michael P. Gray
    Executive Officer
  • Mark W. Noel
    Executive Officer
  • Maurizio Voi
    Executive Officer
  • Susan B. Bayh
    Director
  • Martyn D. Greenacre
    Director
  • Kenneth I. Kaitin
    Director
  • Robert E. Martell
    Director
  • James R. McNab, Jr.
    Director
  • Marc Rubin
    Director
  • James R. Tobin
    Director